| 3CLpro | SARS-CoV2 main protease |
| ACE2 | angiotensin-converting enzyme 2 |
| ADME | administration, distribution, metabolism, and elimination |
| COVID-19 | Coronavirus infectious disease |
| CRD | cysteine-rich domain |
| FDA | Food and Drug Administration |
| FLEX | flexibility |
| GPCR | G protein-coupled receptor |
| HIV | human immunodeficiency virus |
| INSOLU | insolubility |
| INSATU | instauration |
| LDLRA | low-density lipoprotein receptor domain |
| LIPO | lipophilicity |
| NMR | nuclear magnetic resonance |
| PDB | Protein Data Bank |
| PLpro | SARS-CoV2 papain-like protease |
| POLAR | polarity |
| SARS-CoV2 | Severe Acute Respiratory Syndrome Coronavirus type 2 |
| SARS-CoV | Severe Acute Respiratory Syndrome Coronavirus type 1 |
| SPD | serine protease domain |
| Tmprss2 | transmembrane serine protease type II |